Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | IL1-a | 47.5 | 58 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | IL1-a | 71.0 | 67 | |
N2586 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | IL1-a | 55.0 | 66 | |
N2586 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 3 | IL1-a | 59.5 | 60 | |
N2586 | Sigma A6730 | 3.0 | uM | 3 | IL1-a | 74.0 | 51 | ||||
RA2159 | IL-1 alpha | 100 | ng/mL | 3 | IL1-a | 26973.0 | 58 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL1-a | 22787.0 | 59 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL1-a | 27030.0 | 87 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL1-a | 21510.0 | 72 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL1-a | 21236.0 | 70 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL1-a | 22719.0 | 67 | |
RA2159 | PI103 | 0.1 | uM | 3 | IL1-a | 74.5 | 56 | ||||
N2586 | IL-1 alpha | 100 | ng/mL | 3 | IL1-a | 24327.0 | 66 | ||||
N2586 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL1-a | 24087.0 | 75 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL1-a | 18156.5 | 58 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL1-a | 22627.5 | 48 | |
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL1-a | 23916.5 | 72 | |
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL1-a | 15323.0 | 71 | |
N2586 | PI103 | 0.1 | uM | 3 | IL1-a | 50.0 | 59 | ||||
0 | IL1-a | 89.0 | 58 | ||||||||
RA2159 | TNF-a | 100 | ng/mL | 3 | IL1-a | 472.0 | 57 | ||||
RA2159 | PD184352 | 0.1 | uM | TNF-a | 100 | ng/mL | 3 | IL1-a | 64.0 | 53 | |
RA2159 | Lestaurtinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | IL1-a | 82.0 | 69 | |
RA2159 | Ruxolitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | IL1-a | 75.5 | 38 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | IL1-a | 66.5 | 76 |